Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

It’s in the brain: An opinionated take on NEJM highlights for April 2019

  • NEJM
He’s dead, Jim As previously widely advertised, the BACE-1 inhibitor v…

Read more

Two steps forward, one step back: an opinionated take on NEJM highlights for January 2018

  • NEJM
Playing chess against cancer Tumors are not intelligent, but, because …

Read more